Cellectis Announces Completion of the Additional Equity
Completion of the additional equity investment of $140M by AstraZeneca, as previously announced on November 1 and 15, 2023 NEW ...
Read moreCompletion of the additional equity investment of $140M by AstraZeneca, as previously announced on November 1 and 15, 2023 NEW ...
Read moreMIAMI, April 23, 2024 (GLOBE NEWSWIRE) -- Smart for Life, Inc. (Nasdaq: SMFL) (“Smart for Life” or the “Company”), a ...
Read moreTORONTO, April 10, 2024 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a ...
Read moreThis multinational Phase III study is evaluating leniolisib tablets in children aged 4 to 11 years with APDS, a rare ...
Read moreTORONTO, April 04, 2024 (GLOBE NEWSWIRE) -- Further to its news release dated March 27, 2024, Quisitive Technology Solutions Inc. ...
Read moreTiger Aesthetics Medical, LLC is the successful bidder for certain assets used in Sientra’s breast reconstruction and augmentation business Nuance ...
Read moreAzafaros announces completion of 12-week Phase 2 RAINBOW study evaluating lead asset nizubaglustat in rare disease patients Major milestone reached ...
Read moreNOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, ...
Read moreNot for distribution to United States newswire services or for dissemination in the United States. VANCOUVER, BC, Feb. 23, 2024 ...
Read moreSafety and initial efficacy data from Stage 1 expected in the first half of 2024 Dose selection and initiation of ...
Read more© 2015 - 2024 LifeCare News - LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283 - Lifecarenews.in.
© 2015 - 2024 LifeCare News - LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283 - Lifecarenews.in.